Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity

Gian Maria Busetto; Francesco Del Giudice; Martina Maggi; Gabriele Antonini; Daniele D’Agostino; Daniele Romagnoli; Alessandro Del Rosso; Marco Giampaoli; Paolo Corsi; Katie Palmer; Matteo Ferro; Giuseppe Lucarelli; Daniela Terracciano; Ottavio De Cobelli; Alessandro Sciarra; Ettore De Berardinis; Angelo Porreca

doi:doi:10.18632/aging.102883

← Back

Research Paper Volume 12, Issue 5 pp 4337—4347

Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity

Figure 2. Immunohistochemical evaluation of prostatic tissue of a patient in 5ARI group - higher expression of MVD (CD34), brown stained spot coloring vessels (x200).